XLON
DOCS
Market cap1.01bUSD
Jul 04, Last price
76.90GBP
1D
-1.09%
1Q
56.56%
IPO
-82.87%
Name
Dr Martens PLC
Chart & Performance
Profile
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | |
Income | |||||||||
Revenues | 877,100 -12.32% | 1,000,300 10.13% | |||||||
Cost of revenue | 374,200 | 436,400 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 502,900 | 563,900 | |||||||
NOPBT Margin | 57.34% | 56.37% | |||||||
Operating Taxes | 23,800 | 30,500 | |||||||
Tax Rate | 4.73% | 5.41% | |||||||
NOPAT | 479,100 | 533,400 | |||||||
Net income | 69,200 -46.31% | 128,900 -28.86% | |||||||
Dividends | (57,800) | (58,400) | |||||||
Dividend yield | 6.68% | 4.10% | |||||||
Proceeds from repurchase of equity | (50,500) | ||||||||
BB yield | 5.84% | ||||||||
Debt | |||||||||
Debt current | 55,400 | 28,100 | |||||||
Long-term debt | 603,900 | 417,700 | |||||||
Deferred revenue | 124,300 | ||||||||
Other long-term liabilities | 6,300 | 4,400 | |||||||
Net debt | 547,200 | 287,300 | |||||||
Cash flow | |||||||||
Cash from operating activities | 167,900 | 71,700 | |||||||
CAPEX | (18,200) | (51,400) | |||||||
Cash from investing activities | (25,500) | (52,200) | |||||||
Cash from financing activities | (185,900) | (92,300) | |||||||
FCF | 432,700 | 337,300 | |||||||
Balance | |||||||||
Cash | 111,100 | 157,500 | |||||||
Long term investments | 1,000 | 1,000 | |||||||
Excess cash | 68,245 | 108,485 | |||||||
Stockholders' equity | 1,757,200 | 404,200 | |||||||
Invested Capital | 783,255 | 744,515 | |||||||
ROIC | 62.72% | 94.13% | |||||||
ROCE | 58.87% | 65.97% | |||||||
EV | |||||||||
Common stock shares outstanding | 985,600 | 1,001,200 | |||||||
Price | 0.88 -38.33% | 1.42 -40.41% | |||||||
Market cap | 864,864 -39.30% | 1,424,708 -40.51% | |||||||
EV | 1,412,064 | 1,712,008 | |||||||
EBITDA | 575,200 | 618,100 | |||||||
EV/EBITDA | 2.45 | 2.77 | |||||||
Interest | 32,200 | 18,700 | |||||||
Interest/NOPBT | 6.40% | 3.32% |